Canadian Regulation Fish

7/10/2014
Appendices - Standards and Methods Manual - Food - Canadian Food Inspection Agency
Canadian Food Inspection Agency

Home > Food > Fish and Seafood > Manuals > Standards and Methods
Share this page
Standards and
Methods Manual
Appendices
Appendix 1(A) - CFIA Aquaculture Therapeutant Residue Monitoring List
Appendix 1(B) - Therapeutant Use in Aquaculture - Questions and Answers
Appendix 2 - Bacteriological Guidelines for Fish and Fish Products (end product)
Appendix 3 - Canadian Guidelines for Chemical Contaminants and Toxins in Fish and
Fish Products
Appendix 1(A) - CFIA Aquaculture Therapeutant Residue Monitoring List

PDF (99 kb)
This reference list identifies the therapeutants that are currently being monitored in imported and
domestically produced aquacultured fish and crustaceans for compliance with Canadian regulatory
requirements.
General information on therapeutant use in aquaculture in Canada can be found in Appendix 1 (B) Therapeutant Use in Aquaculture - Questions and Answers
Monitoring List Legend / Explanatory Notes
Canadian Food Inspection A gency A quaculture Therapeutant Residue Monitoring List
Class Name
A mphenicols
A mphenicols
Substance Name
Florfenic ol
Marker Residue /
Metabolite
Regulatory
Use Status
Florfenic ol amine
A pproved
Salmonids
M us c le
0 .8
A ction
Level*:
ng/g
(ppb)
a
800
C hloramphenic ol
N /A
Banned
A ll
N /A
DT C
DT C
T hiamphenic ol
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
E mamec tin
Benzoate
N /A
A pproved
Salmonids
M us c le
0 .1
I vermec tin
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
N /A
A pproved
Salmonids
M us c le
0 .3
300
Salmonids
Skin
3 .2
3200
T eflubenzuron
AMRL
AMRL
100
A vermectins
Benzoylureas
Tissue
A mphenicols
A vermectins
A ction
Level*:
g/g
(ppm)
Species
T eflubenzuron
N /A
A pproved
1
Benzoylureas
C iprofloxac in
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
0 .0 0 1
1 .0
D anofloxac in
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
0 .0 0 1
1 .0
E nrofloxac in
N /A
N ot
A ll
N /A
0 .0 0 1
1 .0
Fluoroquinolones
Fluoroquinolones
http://www.inspection.gc.ca/food/fish-and-seafood/manuals/standards-and-methods/eng/1348608971859/1348609209602?chap=7#s17c7
1/15
7/10/2014
E nrofloxac in
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
0 .0 0 1
1 .0
Sarafloxac in
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
0 .0 0 1
1 .0
E rythromyc in
N /A
EDR
Fis h,
C rus tac eans
M us c le
0 .0 3
Furaltadone
(A M O Z) 3 A mino- 5 morphinomethyloxazolidin- 2 - one
Banned
A ll
N /A
DT C
DT C
Furazolidone
(A O Z) 3 - A mino2 - oxazolidinone
Banned
A ll
N /A
DT C
DT C
N itrofurantoin
(A H D ) 1 A minohydantoin
hydroc hloride
Banned
A ll
N /A
DT C
DT C
N itrofurazone
(SE M )
Semic arbazide
Banned
A ll
N /A
DT C
DT C
N /A
Banned
A ll
N /A
DT C
DT C
Nitroimidazoles
2 - hydroxymethyl1 - methyl- 5 nitroimidazole

(H M M N I )
Nitroimidazoles
I pronidazole (I P Z)
N /A
Banned
A ll
N /A
DT C
DT C
N /A
Banned
A ll
N /A
DT C
DT C
Nitroimidazoles
1 - methyl- 2 - (2 'hydroxyis opropyl)5 - nitroimidazole

(I P Z- O H )
Nitroimidazoles
M etronidazole
(M N Z)
N /A
Banned
A ll
N /A
DT C
DT C
N /A
Banned
A ll
N /A
DT C
DT C
Nitroimidazoles
1 - (2 hydroxyethyl)- 2 hydroxymethyl- 5 nitroimidazole

(M N Z- O H )
Nitroimidazoles
Ronidazole (RN Z)
N /A
Banned
A ll
N /A
DT C
DT C
Nitroimidazoles
D imetridazole
(D M Z)
N /A
Banned
A ll
N /A
DT C
DT C
Flumequine
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
O xolinic A c id
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Stilbenes
D ienes trol (D I E N )
N /A
Banned
A ll
N /A
DT C
DT C
Stilbenes
D iethyls tilbes trol

(D E S)
N /A
Banned
A ll
N /A
DT C
DT C
Stilbenes
H exes trol (H E X)
N /A
Banned
A ll
N /A
DT C
DT C
O rmetoprim
N /A
A pproved
Salmonids
E dible
T is s ue
0 .1
Salmonids
E dible
T is s ue
0 .1
Salmonids
E dible
T is s ue
0 .1
Salmonids
M us c le
0 .1
Fluoroquinolones
Fluoroquinolones
Macrolides
Nitrof urans
Nitrof urans
Nitrof urans
Nitrof urans
Quinolones
Quinolones
Sulf onamides
Sulf onamides
Sulf onamides
Sulf onamides
Sulfadiazine
N /A
A pproved
1
Sulfadimethoxine
N /A
A pproved
1
T rimethoprim
N /A
A pproved
1
AMRL
30
100
AMRL
100
AMRL
100
AMRL
100
2/15
7/10/2014
Sulf onamides
T rimethoprim
N /A
100
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Sulfac hloropyridazine
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Sulfadoxine
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Sulfaguanadine
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Sulfamerazine
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Sulfamethazine
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Sulfamethiazole
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Sulfamethoxazole
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Sulfamethoxypridazine
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Sulfamonomethoxine
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Sulfamoxole
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Sulfanilamide
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Sulfapyridine
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Sulfaquinoxaline
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Sulfathiazole
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
Sulfis oxazole
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
O xytetrac yc line
N /A
A pproved
Salmonids ,
M us c le
0 .2
200
Sulf onamides
Sulf onamides
Sulf onamides
Sulf onamides
Sulf onamides
Sulf onamides
Sulf onamides
Sulf onamides
Sulf onamides
Sulf onamides
Tetracyclines
0 .1
N /A
Sulf onamides
Sulf onamides
M us c le
Sulfac etamide
Sulf onamides
Sulf onamides
Salmonids
Sulf onamides
Sulf onamides
A pproved
3/15
7/10/2014
Tetracyclines
O xytetrac yc line
N /A
A pproved
1
Salmonids ,
L obs ters
M us c le
0 .2
200
C hlorotetrac yc line
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
T etrac yc line
N /A
N ot
ac c epted
to be
us ed
A ll
N /A
DT C
DT C
G entian V iolet
L euc ogentian
V iolet
N ot
ac c epted
to be
us ed
A ll
N /A
notes
f, g
notes
f, g
M alac hite G reen
L euc omalac hite

G reen
N ot
ac c epted
to be
us ed
A ll
N /A
notes
d, e
notes
d, e
Tetracyclines
Tetracyclines
Triphenylmethane Dyes
Triphenylmethane Dyes
*Action Level Column

For therapeutants where a predetermined guideline has been established by Health Canada (such as
Maximum Residue Limits (MRLs), Administrative Maximum Residue Limits (AMRLs), interim guidelines,
minimum performance Limit of Quanitification, etc.), the analytical laboratory must use a validated
method that is capable of providing an accurate result so that an assessment can be made on
whether the product meets the applicable guideline. The residue limits for these therapeutants in the
sample are identified in the "Action Level" column.
For therapeutants where a predetermined guideline has not been established by Health Canada and
are not accepted for use in aquaculture in Canada, any residue detected in the sample is a violation
of Article 4 (a) and/or (d) of the Food and Drugs Act and Section 6 (1) (a) of the Fish Inspection
Regulations. The analytical laboratory must use a validated method and report any of these
residues that are detected and positively confirmed by Mass Spectrometry (MS). The action level is
indicated as "DTC" (i.e. Detected above the reporting limit) in the "Action Level" column.
Lot Acceptance
A lot of fish is considered unacceptable when residues of a substance found in the product exceed
the action level specified in this list.
(Note: for Triphenylmethane Dyes - refer to notes d, e, f and g for relevant information).
Monitoring List Legend / Explanatory Notes

Abbreviations / Terms
AMRL - Administrative Maximum Residue Limit: The definition for AMRL and MRL are basically
the same except AMRL is awaiting completion of the legal process for publishing in Food and Drug
Regulations.
DTC - Detected above the reporting limit
EDR - Emergency Drug Release: Program administered by Health Canada - Veterinary Drugs
Directorate.
Edible Tissue: includes muscle and skin
MRL - Maximum Residue Limit: As stipulated in Food and Drug Regulations, Division 15, Table III.
Established value is found in the "Action Level" Column.
Notes:
1 Approved - Veterinary drugs authorized for sale by Health Canada for use in food-producing
aquatic animals
4/15
7/10/2014
Action levels presented are derived from Health Canada - Veterinary Drugs Directorate:
Table 1. Administrative Maximum Residue Limits (AMRLs) and Maximum Residue Limits
(MRLs) set by Health Canada
2 Banned drugs are those drugs which are prohibited for sale and use on animals (including fish) that
produce food or that are intended to be consumed as food as stipulated in the Food and Drug
Regulations (s. B.01.048 and C.01.610.1).
a A lot of fish will be considered reject when the sum of florfenicol (parent drug) and florfenicol
amine (metabolite) detected in the sample exceeds the florfenicol MRL.

b As a minimum performance level of the laboratories testing for fluoroquinolones, the laboratory
must have a limit of quantification (LOQ) of at least 1.0 ng/g for fluoroquinolones.
c Interim action level set by Health Canada.
Malachite Green and Leucomalachite Green Notes

d As a minimum performance level of the laboratories testing for Malachite Green (MG) or
Leucomalachite Green (LMG), the laboratory must have a limit of quantification (LOQ) of at least 0.5
ng/g for MG or LMG.
e The "Interim Guidelines for the Presence of Malachite Green (MG) and Leucomalachite Green (LMG)
in Aquaculture Fish Products" established by Health Canada and published in the CFIA Industry
Notice of March 29, 2006 are as follows:
Malachite green is not permitted in Canada for use during any part of the aquaculture fish
production life-cycle.
The interim guidelines from Health Canada and CFIA's product acceptability criteria applicable
to imported and domestic fish products are described below:
MG or LMG Levels
0.50 ng/g for MG or LMG
(Interim LOQ for MG or LMG)
> 1.00 ng/g for MG or LMG
> 0.50 ng/g to 1.00 ng/g
for MG or LMG
(Note: Gathering of
information will be required
to determine deliberate use)
Product Action
No regulatory actions will be taken.
Product is unacceptable. Appropriate regulatory actions will be

taken.
Product is unacceptable unless a review of information
gathered shows there has been no deliberate use. Appropriate
regulatory actions will be taken, as required.
For products found to contain levels > 0.50 and 1.00 ng/g of MG or LMG, the following approach
will be used:
Importers will have the option of gathering information in order to provide evidence of nondeliberate use. The importers should contact the local CFIA office. On a case by case basis,
the CFIA will determine when the option for gathering information is available. This will be
based on the importer's Quality Management Program and/or on the presence of foreign
arrangements or regulatory links with the respective foreign authorities. CFIA will take the
appropriate regulatory action.
Federally registered processors will be required to notify the CFIA of these results and take
the appropriate corrective actions according to their QMP plan. Appropriate corrective
actions should include gathering information to determine if deliberate use of MG occurred
during any part of the aquaculture fish production life cycle. The processor will provide their
findings to the CFIA and the information will be reviewed to determine the regulatory
compliance. The CFIA may complete a Compliance Verification to determine whether the QMP
requirements have been met.
5/15
7/10/2014
Gentian Violet and Leucogentian Violet Notes

f As a minimum performance level of the laboratories testing for Gentian Violet (GV) or Leucogentian
Violet (LGV), the laboratory must have a limit of quantification (LOQ) of at least 0.5 ng/g for GV or
LGV.
g Gentian violet is not permitted in Canada for use during any part of the aquaculture fish production
life-cycle.
As a result of on-going discussions with Health Canada regarding Gentian Violet as a therapeutant
and as a possible contaminant, the interim guidelines for the presence of GV and LGV and CFIA's
product acceptability criteria applicable to imported and domestic aquacultured fish products have
been modified as follows:
Interim guidelines from Health Canada and Canadian Food Inspection Agency's product
acceptability criteria applicable to imported and domestic fish products
GV or LGV Levels
< 0.50 ng/g for GV and/or LGV
(Interim LOQ for GV or LGV)
Product Action
No regulatory actions will be taken.
Sum GV & LGV 1.0 ng/g

Specifically:
GV 1.0 ng/g & LGV < 0.5
ng/g or
GV < 0.5 ng/g & LGV 1.0
ng/g or
GV 0.5 ng/g & LGV 0.5
ng/g
Product is unacceptable. Appropriate regulatory actions will

be taken.
GV < 0.5 ng/g & LGV 0.5

ng/g and < 1.0 ng/g or
GV 0.5 ng/g and < 1.0 ng/g
& LGV < 0.5 ng/g
This result will trigger a follow-up investigation for possible

therapeutant use prior to making a lot decision.
GV 0.5 ng/g & LGV not

detected at the reporting limit
This result will trigger a follow-up investigation for possible

post harvest contamination prior to making a lot decision.
When a follow up investigation is needed, laboratory reports/results (i.e. from a QMPI importer)
should be forwarded to a CFIA inspector.
The CFIA Inspector will communicate with their respective Regional/Area Program Staff who will liase
with the National Manager Technical Standards (or delegate), Fish, Seafood and Production Division.
The follow up investigation approach may include, but not limited to gathering evidence of nondeliberate use, collecting and reviewing additional information, etc., for an assessment and this will
be determined on a case by case basis.
Teflubenzuron Notes
h The monitoring of teflubenzuron in aquaculture products is under review and is not applicable at
this time.
Version: February 12, 2013
Appendix 1(B) - Therapeutant Use in Aquaculture - Questions and Answers

Preamble: This document outlines key information, for importers and domestic processors of fish
and fish products, on the Canadian regulatory and testing requirements for therapeutants in
aquaculture production. Fish importers and domestic processors are responsible for ensuring product
compliance by implementing measures to address therapeutants in aquacultured fish and
crustaceans intended for human consumption.
6/15
7/10/2014
General
What are therapeutants and why are they used in aquaculture?
Therapeutants are chemical substances used on fish farms or aquaculture operations when
necessary to keep aquatic animals (i.e. fish or crustaceans) healthy while they are being raised.
Therapeutants could be drugs or pesticides.
In Canada, therapeutants are prescribed by licensed veterinarians after they have diagnosed health
problems in aquatic animals under their care. Veterinarians are responsible for treatment using the
prescribed therapeutant on the fish farm and are also involved with the aquaculture operator to
ensure that the treated fish or crustaceans are safe for human consumption.
While other countries may have different procedures for administrating therapeutants, the final fish
product imported into Canada must be safe for human consumption.
What is a veterinary drug?

A veterinary drug is a therapeutant that is used to treat a disease in aquatic animals and is usually
given to them to consume (for example, through medicated feed). However, some drugs may be
given by injection. At this moment, most aquaculture therapeutants in Canada are delivered through
feed and are regulated by Health Canada's Veterinary Drugs Directorate (VDD) under the Canadian
Food and Drugs Act and Regulations. For information on veterinary drugs and the VDD consult
the Web site.
What is a pesticide?
When certain therapeutants (such as some antiparasitic products) are added to the water to
specifically control only external parasites (i.e. topically applied to fish by submersion in a bath),
they are deemed a pesticide and are regulated under the Canadian Pest Control Products Act and
Regulations. The Pest Management Regulatory Agency (PMRA) within Health Canada approves
pesticides under the Pest Control Products Act. Information on pesticides and the PMRA can be
found at the Health Canada website.
Key Roles in Food Safety

Health Canada: Setting the Standards
What is Health Canada's role with respect to veterinary drugs?
The Veterinary Drugs Directorate (VDD) within Health Canada is responsible for protecting human
and animal health and the safety of Canada's food supply. Through the VDD, Health Canada
evaluates and monitors the safety, quality and effectiveness, sets standards and promotes the
prudent use of veterinary drugs administered to food-producing and companion animals. For drug
products used in food-producing animals, VDD establishes mandatory withdrawal times and sets
maximum residue limits (MRLs) and administrative maximum residue limits (AMRLs) for veterinary
drugs after it has conducted an extensive review of data submitted by manufacturers and has
assessed the veterinary drugs' safety and risk.
What is a Maximum Residue Limit (MRL)?

A Maximum Residue Limit (MRL) is an amount of drug residue present in treated aquatic animals that
will not pose adverse human health effects if the food is consumed daily over a lifetime. A MRL
applies to a specific tissue for a specific species. For example, sulfadiazine (in the approved drug,
Tribressen 40% Powder), a drug approved for use in salmonids in Canada, could be administered to
salmonids and the residual level in the edible tissues of fish offered for sale cannot exceed the MRL
of 0.1 g/g.
What is an Administrative Maximum Residue Limit (AMRL)?

The definition of an Administrative Maximum Residue Limit (AMRL) and a MRL are basically the same
7/15
7/10/2014
since the process and rigour that the VDD uses to assess the safety and risk of a veterinary drug
are the same. The only difference is that, for an AMRL, the Canadian legal process to publish this
information in the Food and Drug Regulations is in progress. Once the legal process is complete, the
AMRL is officially known as an MRL. While their legal status differ, there is no difference between an
MRL and AMRL in terms of scientific validity and thus the VDD posts a formal list of established
AMRLs on its website. In this context, AMRLs can be a factor in considering if a food is acceptable
for sale in Canada and considering action to be taken where the possible adulteration of foodstuffs is
suspected or known.
How does Health Canada establish a MRL for a veterinary drug or expand the
scope of application of an existing MRL to a new species or target tissue?
MRLs are established only after the VDD has conducted extensive reviews of data submitted by
manufacturers and has determined that foods containing these veterinary drug residues up to the
established levels are safe for human consumption. Health Canada's website provides additional
information on the risk assessment and approval process for establishing MRLs.
What if a veterinary drug, which has not been approved by Health Canada, is
needed for the emergency treatment of aquatic animals in Canada?
Health Canada may provide, under the Emergency Drug Release (EDR) program, an authorization for
the sale of a drug, under the Food and Drug Regulations1. This authorization permits the
manufacturer of a new drug to sell a limited quantity of the new drug to a veterinarian.
The new drug is one which is not marketed in Canada and is requested by a veterinarian as
an emergency treatment for aquatic animals under his or her care.
Before the request is authorized, the veterinarian must provide the VDD with detailed
information regarding the emergency treatment of the aquatic animal(s), safety data
(including human safety) of the drug, and any other relevant information. Once the
evaluation has been completed, the VDD may issue the EDR authorization along with the
conditions which must be met (for example, adhering to a withdrawal time).
Veterinarians are responsible for reporting on the drug use results. Health Canada's website
provides additional information on the Emergency Drug Release program
What if a pesticide, which has not been approved by Health Canada, is needed for
the emergency treatment of aquatic animals in Canada?
The Pest Management Regulatory Agency (PMRA) within Health Canada may grant emergency
release permits for pesticides under the Pest Control Products Act.
Industry: Implementing Controls and Verifying Product Safety

What do importers and domestic processors need to know about therapeutant
use in aquacultured fish and crustaceans?
Fish importers and domestic processors should be aware that not all therapeutants that may be
accessible to fish farms or aquaculture operations are accepted to be used in aquacultured aquatic
animals intended for human consumption. Importers and domestic processors should be
knowledgeable of therapeutants which are "banned", "approved" and "accepted to be used" in
Canada in relation to aquacultured products so that they can take actions to reduce or eliminate the
consumer exposure to therapeutants that may pose a food safety risk.
What are "banned" drugs?

According to the Food and Drug Regulations2, banned drugs are those drugs which are prohibited
for sale for administration to animals that produce food or that are intended to be consumed as food
because the drug contains one of the following:
chloramphenicol or its salts and derivatives;
a 5-nitrofuran compound;
clenbuterol or its salts and derivatives;
8/15
7/10/2014
a 5-nitroimidazole compound or;

diethylstilbestrol or other stilbene compounds.
Scientific evidence has shown that exposure to these substances is unsafe for consumers. Fish and
crustaceans containing any residue from these drugs are in violation of the Food and Drug
Regulations3 and the Fish Inspection Regulations and would not be permitted for sale in the
Canadian market.
What are "approved" drugs in Canada?

Drugs that have a Drug Identification Number (DIN) on the label are drugs that are approved by
Health Canada. A list of veterinary drugs approved for sale by Health Canada to be used in aquatic
animals can be found at the Health Canada website.
Any drug residue present in the food must not exceed the MRL or AMRL for that drug set by Health
Canada.
Which therapeutants are "accepted to be used" in aquaculture in Canada?

A therapeutant "accepted to be used" in aquaculture in Canada can be either of the following:
A drug authorized for sale by Health Canada to be used specifically in aquatic animals.
Health Canada's website provides additional information.
A drug authorized for sale by Health Canada through an Emergency Drug Release (EDR) when
the drug has not been approved in Canada;
A drug authorized for sale by Health Canada for testing purposes under an Experimental
Studies Certificate (ESC);
A drug authorized for sale by Health Canada as an Investigational New Drug Submission for
clinical trials;
A drug, prescribed by a licensed veterinarian, as extra-label drug use (ELDU) (only applies to
products with a Drug Identification Number (DIN) assigned by Health Canada). Please refer to
the ELDU Policy Statement of Health Canada for more information.
A pesticide that is approved to be used in aquatic animals by the Pest Management
Regulatory Agency (PMRA) within Health Canada. This pesticide should be used according
exactly to the label instructions;
A pesticide which has been granted an emergency release permit by PMRA under the Pest
Control Products Act.
Can I import or process fish products that contain therapeutants not "accepted to
be used" in aquaculture in Canada?
No, any therapeutants which are not considered "accepted to be used" are essentially unapproved
and their residues should not be present in fish offered for sale in Canada.
How can importers provide assurances regarding the safety of the aquaculture
products they import with respect to therapeutants?
All importers should be aware that there could be a food safety risk associated with therapeutants in
the aquaculture products they import. To help ensure that consumers are not exposed to noncompliant products, importers are responsible for discussing the potential of therapeutant use and
residues in aquaculture products with their suppliers. Fish importers need to take affirmative actions
when sourcing product by dealing with suppliers that can provide assurances that the products meet
the applicable Canadian requirements and do not contain illegal drug residues. Affirmative actions
may include, but are not limited to, providing suppliers with a description of all Canadian regulatory
standards for aquaculture products as a part of their product specification outlined in a buyer-seller
agreement or selecting producers that use a Hazard Analysis Critical Control Point (HACCP) based
system in the production of their fish and seafood products.
Find additional information on affirmative actions and importing fish and seafood products into
Canada.
Quality Management Program Importer (QMPI) licence holders must verify that each lot of imported
9/15
7/10/2014
aquatic animals complies with Canadian regulatory requirements and applicable product standards by
conducting inspection activities as outlined in their QMPI plan. The QMPI licence holder is also
required to review their QMPI plan annually and perform routine verification activities as appropriate,
to ensure it is functioning effectively.
How can domestic processors provide assurances regarding the safety of the
aquaculture products they process with respect to therapeutants?
Domestic processors should discuss the potential for therapeutant use and residues with their
suppliers of aquaculture products when establishing drug residue controls under their Quality
Management Program (QMP) plan. Buyer-seller agreements, such as a Supplier Quality Assurance
(SQA) agreement and/or product testing are examples of measures that can be implemented to
assure that the product meets Canadian requirements. Processors should also ensure that their
SQAs and/or HACCP plan related to therapeutants are kept up to date as needed.
Domestic processors must conduct monitoring activities so that each lot of incoming aquatic animals
complies with Canadian regulatory requirements and applicable product standards as outlined in their
QMP plan. The processor is also required to review their QMP plan annually and perform routine
verifications, including their HACCP plan, to ensure it is functioning effectively.
When establishing drug residue controls, establishments that process aquacultured aquatic animals
in Canada should also give consideration to Health Canada's Emergency Drug Release Program, which
allows veterinarians controlled access to drugs which have not been approved for use in
aquaculture.
What is the policy for using private laboratory services to test fish and fish
products for therapeutants to determine regulatory compliance?
Importers and domestic processors that use a private (third party) laboratory to test fish and fish
products to verify regulatory compliance shall adhere to the CFIA Policy on the Use of Third Party
Laboratories for Testing Fish and Fish Products Under the Fish Inspection Program.
Canadian Food Inspection Agency: Monitoring and Compliance Verification

Activities
What is the Canadian Food Inspection Agency's (CFIA) role with respect to
therapeutants and assuring food safety?
The CFIA's inspection program routinely monitors commercially sold aquaculture products to verify
that the residue limits established by Health Canada have not been exceeded and that the products
do not contain illegal therapeutants. Product analysis, using fully validated methods, are performed
in accredited CFIA laboratories based on an ISO 17025 system. The CFIA will take appropriate
regulatory action on non-compliant aquaculture products.
By conducting product monitoring and other verification activities, the CFIA is able to assess
whether effective controls have been implemented by domestic processors and licensed importers
that will provide reasonable assurance that aquaculture products consistently meet Canadian
regulatory requirements concerning therapeutants.
Where can I find a list of aquaculture therapeutants currently monitored by the

Canadian Food Inspection Agency (CFIA)?
Consult a List of aquaculture therapeutants that the CFIA currently monitors (imported and
domestically produced aquacultured products), including but not limited to, "banned" drugs and
"accepted to be used" therapeutants.
Footnotes:
1 Section C.08.010 and C.08.011 of the Food and Drug Regulations
2 Section C.01.610.1 of the Food and Drug Regulations
10/15
7/10/2014
3 Article B.01.048(1)(2)(d) of the Food and Drug Regulations
Appendix 2 - Bacteriological Guidelines for Fish and Fish Products (end

product)
PDF (343 kb)
Table of bacteriological levels with organism, product and acceptance numbers
Test Organism1
Product Type
Number
of sample
units
A cceptance number (c)2
m/g2
M/g2
Criteria f or
action
40
Escheri chi a col i
C ooked or
ready- to- eat
produc ts
Rejec t if 2 or
more units
exc eed m, or if
any unit
exc eeds M
2 3 0 /1 0 0
g
3 3 0 /1 0 0
g
Escheri chi a col i
Raw
mollus c an
s hellfis h
Rejec t if 2 or
more units
exc eed m, or if
any unit
exc eeds M
A ll other
types
40
Rejec t if 3 or
more units
exc eed m, or if
any unit
exc eeds M
A ll types
1000
10000
Rejec t if 2 or
more units
exc eed m, or if
any unit
exc eeds M
A ll types
A bs ent in eac h 2 5 g
s ample or in pooled
s amples of 1 2 5 g.
Rejec t if
Salmonella s pp
is detec ted
C ooked or
ready- to- eat
produc ts
A bs ent in eac h 2 5 g
s ample or in pooled
s amples of 1 2 5 g
Rejec t if Vibrio
cholerae is
detec ted.
Raw O ys ter
100
10000
Rejec t if 2 or
more units
exc eed m, or if
any unit
exc eeds M
Escheri chi a col i
Coagulase-Positive
Sta phy l ococci
Sa l monel l a spp.
Vi bri o chol era e
Vi bri o
pa ra ha emol y ti cus
Listeria monocytogenes
Listeria monocytogenes (From Health Canada's "Policy on Listeria monocytogenes in Ready-toEat Foods")
Policy on Listeria monocytogenes in Ready-to-Eat Foods
Product Type / Category 3
Laboratory method
to be applied
Action
Level
RTE Fish products in which the growth of L.

monocytogenes can occur and could exceed 100
CFU/g before the end of the stated shelf-life.
Includes all products that do not fall in either belowmentioned product types.
(Equivalent to Category 1 foods in the HC Listeria
policy)*
Presence/absence
in 125 g
(MFHPB-30 6) on 5
sample units of 25 g
each
Detected
RTE Fish products in which the growth of L.

monocytogenes can occur but is limited to levels no
greater than 100 CFU/g over the course of their
stated shelf-life.
Enumeration in 50 g
(MFLP-74 6) on 5
each
> 100
CFU/g 5
11/15
7/10/2014
stated shelf-life.
RTE products that have a refrigerated shelf-life of 5
days or less fall under this category.
Other products require validation data 4
demonstrating growth cannot exceed 100 CFU/g 5.
(Equivalent to Category 2A foods in the HC Listeria
policy *)
each
RTE Fish products in which growth of L.

monocytogenes can not occur over the course of the
stated shelf-life.
Products with the following characteristics fall under
this category:
Enumeration in 50 g
(MFLP-74 6) on 5
each
> 100
CFU/g 5
products that are frozen, or

have a pH < 4.4 regardless of the aw, or
have an aw < 0.92 regardless of the pH, or
have a pH < 5.0 and an aw < 0.94
For products that don't meet the above
characteristics, validation data 4 demonstrating the
absence of growth is required.
(Equivalent to Category 2B foods in the HC Listeria
policy *)
Notes:
1 The analysis of all fish or fishery products shall be conducted in accordance with approved
methods
2 m - number of bacteria per gram separating acceptable from marginally acceptable samples, c -
number of samples that may exceed this number of bacteria per gram, M - no sample can exceed
this number of bacteria per gram
3 For further guidance on the determination of a product category, see Figure 1 Classification Of
Ready-to Eat Foods in the Health Canada document Validation of Ready-to-Eat Foods for
Changing the Classification of a Category 1 into a Category 2A or 2B Food - in relation to
Health Canada's Policy on Listeria monocytogenes in Ready-to-Eat Foods (2011)
4 See HC's guide on "Listeria monocytogenes Challenge Testing of Ready-to-Eat Refrigerated
Foods" for information on challenge testing as part of validation.

5 Counts between 5 and 100 CFU/g can be an indication of a possible loss of control and should
prompt the processor to verify and/or re-evaluate his process controls.

6 Or any other method published in the Health Canada's Compendium of Analytical Methods for
Listeria monocytogenes in which the "application" section is appropriate for the intended purpose
(e.g., MFHPB-methods and MFLP-methods).
* Health Canada's "Policy on Listeria monocytogenes in Ready-to-Eat Foods" will be referred to as
the "HC Listeria Policy" validation.
Appendix 3 - Canadian Guidelines for Chemical Contaminants and Toxins in

Fish and Fish Products
PDF (34 kb)
Table of levels of contaminants permitted in fish and fish products

Action
12/15
7/10/2014
Contaminants
Product Type
Action
Level 1
Mercury
All fish products (except swordfish, shark, fresh and

frozen tuna, escolar, orange roughy and marlin)
0.5 ppm
Mercury
Swordfish, shark, fresh and frozen tuna, escolar,

orange roughy and marlin
1.0 ppm
Arsenic
Fish protein concentrate
3.5 ppm
Lead
0.5 ppm
Fluoride
150 ppm
All fish products
20 ppt
*under
review*
All fish products
5.0 ppm
All fish products
2.0 ppm
*under
review*
Piperonyl butoxide
Dried Cod
1.0 ppm
Other agricultural
chemicals or their
derivatives
All fish products
0.1 ppm
2,3,7,8 TCDD (Dioxin)

DDT and metabolites
(DDD and DDE)
PCB
1 Based on contaminants level of edible weight
Notes:
Sampling: Samples to consist of a minimum of 5 units representative of the lot. Analysis may be
carried out on a composite of all sample units.
Criteria for Action: A lot of fish will be considered reject if the sample value exceeds the action
level. Fish or fish products exceeding these guidelines may be permitted for export if they do not
violate regulations of the importing country.
Table of levels of toxins permitted in fish and fish products
Toxins
Product Type
Action
Level
Histamine 2 (Scombroid Poisoning)
Enzyme ripened products (e.g. anchovies,

anchovy paste, fish sauce)
20 mg /
100 g
Histamine 2 (Scombroid Poisoning)
All other scombroid fish products (e.g.

canned or fresh or frozen tuna, mackerel,
mahi-mahi)
10 mg /
100 g
Saxitoxins (PSP) 3
Molluscan shellfish (edible portion)
80 g /
100 g
Domoic Acid (ASP) 3
20 g/g
Okadaic Acid (OA) + DTX1 + DTX2 +

OA esters + DTX1 esters + DTX2
0.2 g /
g
(interim)
esters (DSP) 3
13/15
7/10/2014
esters (DSP) 3
Pectenotoxins:
PTX-1, PTX-2, PTX-3, PTX-4, PTX-6
and PTX-11
0.2 g /
g
Additional Comments:
2 Histamine
Samples are collected according to Sampling Plan 1 (AQL 6.5) for initial inspection and
Sampling Plan 2 (AQL 6.5) for reinspection. See the Sampling Policy and Procedures
Any sample exceeding 50 mg/100 g will result in the lot being rejected with no right to
reinspection.
The acceptance number is that corresponding to the number for decomposition.
3 PSP, ASP and DSP (Paralytic Shellfish Poisoning, Amnesic Shellfish Poisoning - Diarrhetic Shellfish
Poisoning)
Procedures for closure of shellfish areas, and possible recall of product due to samples of
shellfish containing toxin levels equal to or greater than the above action levels can be found
in Chapter 11 of the Canadian Shellfish Sanitation program
The minimum acceptable sample is that which when shucked will produce 100 g of drained
meats from 5 pooled sub-samples. Depending on the size of animals, the total number of
shellfish required varies from 3 (geoduck) to 25 (pink scallops).
Background Levels for Non-permitted Additives
Additive 4
Product Type
Background Level 5
Nitrites
All fish and fish products (except marine mammal meat

6)
15 ppm (see note 2)
Nitrates
All fish and fish products
15 ppm (see note 2)
Sulphites 7
Clams (raw and canned)
10 ppm
Phosphates
Shrimp (raw, cooked and canned)
1.60 %
Scallops (raw)
1.47 %
Fish fillets
1.37 %
Crab (raw and cooked)
1.70 %
Lobster (raw and cooked)
1.47 %
Surf clams (raw and cooked)
1.00 %
Phosphates
8
Phosphates
8
Phosphates
8
Phosphates
8
Phosphates
8
4 The compounds listed in this table are food additives; however some background levels may occur
naturally in some foods.

5 When the additive is not permitted, then the action level is the background level or detection
14/15
7/10/2014
limit; when the additive is permitted, then the action level is the background level or detection limit
plus the permitted amount.
6 Marine mammals, including seals are included in the definition of "fish" as per the Canadian Food
and Drug Regulations. Sodium nitrite is permitted in marine mammal meats at the maximum level of
200 ppm.
7 Calculated as sulphur dioxide.
8 Calculated as sodium phosphate, dibasic.
Note:
1. If a processor can provide reliable data for naturally occurring background levels that are
higher than those shown above, this may be considered before product action is taken.
2. Some herbs, including parsley, contain high levels of naturally occurring nitrates. This has to
be considered when nitrates are detected in fish products containing herbs as an ingredient.
Previous
Table of Contents
Next
Date modified: 2013-08-01
15/15

Canadian Regulation Fish

Uploaded by

Copyright:

Available Formats

Canadian Regulation Fish

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Canadian Regulation Fish

Uploaded by

Copyright:

Available Formats

7/10/2014

Canadian Food Inspection Agency

Appendix 1(A) - CFIA Aquaculture Therapeutant Residue Monitoring List

(A M O Z) 3 A mino- 5 morphinomethyloxazolidin- 2 - one

2 - hydroxymethyl1 - methyl- 5 nitroimidazole

1 - methyl- 2 - (2 'hydroxyis opropyl)5 - nitroimidazole

1 - (2 hydroxyethyl)- 2 hydroxymethyl- 5 nitroimidazole

D iethyls tilbes trol

M alac hite G reen

L euc omalac hite

*Action Level Column

Monitoring List Legend / Explanatory Notes

amine (metabolite) detected in the sample exceeds the florfenicol MRL.

Malachite Green and Leucomalachite Green Notes

Product is unacceptable. Appropriate regulatory actions will be

Gentian Violet and Leucogentian Violet Notes

Sum GV & LGV 1.0 ng/g

Product is unacceptable. Appropriate regulatory actions will

GV < 0.5 ng/g & LGV 0.5

This result will trigger a follow-up investigation for possible

GV 0.5 ng/g & LGV not

This result will trigger a follow-up investigation for possible

Appendix 1(B) - Therapeutant Use in Aquaculture - Questions and Answers

What is a veterinary drug?

Key Roles in Food Safety

What is a Maximum Residue Limit (MRL)?

What is an Administrative Maximum Residue Limit (AMRL)?

Industry: Implementing Controls and Verifying Product Safety

What are "banned" drugs?

a 5-nitroimidazole compound or;

What are "approved" drugs in Canada?

Which therapeutants are "accepted to be used" in aquaculture in Canada?

Canadian Food Inspection Agency: Monitoring and Compliance Verification

Where can I find a list of aquaculture therapeutants currently monitored by the

3 Article B.01.048(1)(2)(d) of the Food and Drug Regulations

Appendix 2 - Bacteriological Guidelines for Fish and Fish Products (end

A cceptance number (c)2

Escheri chi a col i

Escheri chi a col i

Escheri chi a col i

Vi bri o chol era e

RTE Fish products in which the growth of L.

RTE Fish products in which the growth of L.

RTE Fish products in which growth of L.

products that are frozen, or

Foods" for information on challenge testing as part of validation.

prompt the processor to verify and/or re-evaluate his process controls.

the "HC Listeria Policy" validation.

Appendix 3 - Canadian Guidelines for Chemical Contaminants and Toxins in

Table of levels of contaminants permitted in fish and fish products

All fish products (except swordfish, shark, fresh and

Swordfish, shark, fresh and frozen tuna, escolar,

Fish protein concentrate

Fish protein concentrate

Fish protein concentrate

All fish products

All fish products

All fish products

All fish products